UK says new study vindicates delaying 2nd virus vaccine shot
LONDON (AP) — Britain’s health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks, saying it supports the government’s contentious strategy of delaying the second shot so it can protect more people quickly with a first dose.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
